Nanjing Hicin Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals, pharmaceutical preparations, and synthetic chemicals in China. It offers antivirals, antibiotics, endocrine drugs, gastrointestinal drugs, orthopedic drugs, drugs for cardio-cerebral system, and immuno-modulate agents. The company also provides technical transferring services. In addition, it offers supply chain management services. The company also exports APIs; omeprazole sodium and cefepime hydrochloride for injections; and lansoprazole tablets to South-Asian countries, South-American countries, and European countries. Nanjing Hicin Pharmaceutical Co., Ltd. was founded in 2003 and is headquartered in Nanjing, China.
| 22.27 | |
| 23.9 | |
| - | |
| 23.99 | |
| 22.23 | |
| 12.6393-27.98 | |
| 2 672 M | |
| 63.6286 | |
| 120 M | |
| 500 M | |
| 0.0282 | |
| 0.0022 | |
| 0.198 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Focus to be Remediating the Multi-Billion Ton Global Waste Oil Sludge from Refineries and Midstream Oil Operators First RPC Unit is Fully Funded and is Expected to be Deployed in June with the capaci...
IRVINE, CA / ACCESSWIRE /April 28, 2022/ Vivakor, Inc. (Nasdaq:VIVK) ("Vivakor" or the "Company"), a socially responsible operator, acquirer and developer of clean energy technologies and environmenta...
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
